| scholarly article | Q13442814 |
| P2093 | author name string | Mary P Stenzel-Poore | |
| Rebecca L Williams-Karnesky | |||
| P2860 | cites work | Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia | Q49021460 |
| Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. | Q49044940 | ||
| Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. | Q52172385 | ||
| Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. | Q52948897 | ||
| The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. | Q54765467 | ||
| Brain Adenosine Receptors as Targets for Therapeutic Intervention in Neurodegenerative Diseases | Q57405388 | ||
| The risk of perioperative stroke in patients with asymptomatic carotid bruits undergoing peripheral vascular surgery | Q69262873 | ||
| Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells | Q71464142 | ||
| Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism | Q71573590 | ||
| Perioperative stroke in patients undergoing head and neck surgery | Q72926214 | ||
| Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: A mechanism for methotrexate-induced nodulosis in rheumatoid arthritis | Q73491938 | ||
| Increase in plasma adenosine during brain ischemia in man: a study during transient ischemic attacks, and stroke | Q73515528 | ||
| Effect of adenosine receptor subtypes stimulation on mixed lymphocyte reaction | Q79995941 | ||
| The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation | Q80236428 | ||
| Stimulation of adenosine A2A receptor inhibits LPS-induced expression of intercellular adhesion molecule 1 and production of TNF-alpha in human peripheral blood mononuclear cells | Q80785694 | ||
| Mechanisms of ischemic brain damage | Q80793077 | ||
| Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells | Q81683786 | ||
| Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 | ||
| Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | Q24651475 | ||
| Shaping of monocyte and macrophage function by adenosine receptors | Q24655330 | ||
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage | Q28291855 | ||
| A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice | Q28594915 | ||
| Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors | Q28771718 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| Astrocytes are active players in cerebral innate immunity | Q29620562 | ||
| Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia | Q30309370 | ||
| Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping | Q30439583 | ||
| A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 | ||
| Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells. | Q30440756 | ||
| A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes | Q30444620 | ||
| The A2B adenosine receptor protects against inflammation and excessive vascular adhesion | Q30477474 | ||
| Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice | Q30999748 | ||
| Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro | Q31108561 | ||
| Interleukin-6 enhances expression of adenosine A(1) receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices | Q31657566 | ||
| Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? | Q33650966 | ||
| Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both? | Q33834162 | ||
| Neutrophils: molecules, functions and pathophysiological aspects | Q33903590 | ||
| Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector | Q33916931 | ||
| A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation | Q34159374 | ||
| The role and regulation of adenosine in the central nervous system | Q34205330 | ||
| Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning | Q34357041 | ||
| Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats | Q34485914 | ||
| Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. | Q34487172 | ||
| Toll-like receptor 9: a new target of ischemic preconditioning in the brain | Q34566966 | ||
| Adenosine kinase, epilepsy and stroke: mechanisms and therapies | Q34575897 | ||
| Ischemic tolerance and endogenous neuroprotection | Q35126696 | ||
| Participation of adenosine receptors in neuroprotection. | Q35147807 | ||
| Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats | Q43962255 | ||
| Adenosine A2A analogue improves neurologic outcome after spinal cord trauma in the rabbit | Q44096031 | ||
| Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. | Q44183267 | ||
| The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells | Q44215015 | ||
| The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. | Q44257111 | ||
| Adenosine A(1) receptor antagonist and mitochondrial ATP-sensitive potassium channel blocker attenuate the tolerance to focal cerebral ischemia in rats | Q44969169 | ||
| Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury | Q45078353 | ||
| ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. | Q45930388 | ||
| Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury | Q46046364 | ||
| Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists | Q46910242 | ||
| Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain | Q46937494 | ||
| The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia-in vivo study | Q46979681 | ||
| Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion | Q47281858 | ||
| Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. | Q48195175 | ||
| Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia | Q48198649 | ||
| CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil | Q48216955 | ||
| Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance | Q48258831 | ||
| Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation | Q48386801 | ||
| IL-10 reduces rat brain injury following focal stroke | Q48401527 | ||
| Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. | Q48406066 | ||
| Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro | Q48542641 | ||
| Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury | Q48698077 | ||
| Adenosine receptors and mammalian toll-like receptors: synergism in macrophages. | Q35679612 | ||
| Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis | Q35782047 | ||
| A role for adenosine deaminase in human monocyte maturation | Q35903364 | ||
| Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. | Q35999731 | ||
| Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration | Q36025393 | ||
| Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage | Q36030783 | ||
| Adenosine A3 receptor stimulation and cerebral ischemia | Q36185246 | ||
| Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. | Q36202827 | ||
| What can adenosine neuromodulation do for neuroprotection? | Q36230525 | ||
| Adenosine receptor signaling in the brain immune system | Q36242243 | ||
| Stroke and encephalopathy after cardiac surgery: an update | Q36350953 | ||
| Adenosine promotes neutrophil chemotaxis. | Q36354651 | ||
| Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia | Q36660319 | ||
| Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist | Q36785534 | ||
| Silk polymer-based adenosine release: therapeutic potential for epilepsy | Q36819103 | ||
| Evolving functions of endothelial cells in inflammation | Q36950913 | ||
| TNF-alpha upregulates the A2B adenosine receptor gene: The role of NAD(P)H oxidase 4. | Q36973962 | ||
| T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation | Q36992998 | ||
| Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). | Q37091784 | ||
| Toll-like receptor signaling in endogenous neuroprotection and stroke | Q37171364 | ||
| A2B adenosine receptor dampens hypoxia-induced vascular leak | Q37336475 | ||
| Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil | Q37779405 | ||
| Neuropsychological sequelae of cardiac arrest | Q39411359 | ||
| Adenosine A(1), A(2a), A(2b), and A(3) receptors in hematopoiesis. 2. Expression of receptor mRNA in resting and lipopolysaccharide-activated mouse RAW 264.7 macrophages | Q39878842 | ||
| Adenosine induces expression of glial cell line-derived neurotrophic factor (GDNF) in primary rat astrocytes | Q40071235 | ||
| IL-1 beta and TNF-alpha regulation of the adenosine receptor (A2A) expression: differential requirement for NF-kappa B binding to the proximal promoter | Q40212496 | ||
| Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats | Q40250561 | ||
| Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade | Q40722338 | ||
| Adenosine and lymphocyte regulation | Q40729772 | ||
| Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. | Q40779392 | ||
| Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment | Q40903489 | ||
| Acute ischemic stroke therapy. A clinical overview | Q40910721 | ||
| Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats | Q40911927 | ||
| Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells | Q41210813 | ||
| Adenosine and neuroprotection | Q41301305 | ||
| Peri-operative stroke in general surgical patients | Q41625656 | ||
| Adenosine receptors of cerebral microvessels and choroid plexus | Q42205915 | ||
| Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity | Q42471051 | ||
| Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. | Q42488794 | ||
| Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. | Q42495104 | ||
| Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke | Q42912296 | ||
| Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage | Q43642590 | ||
| Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. | Q43770564 | ||
| Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist | Q43874157 | ||
| Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation | Q43928343 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 217-227 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Current Neuropharmacology | Q20181354 |
| P1476 | title | Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant | |
| P478 | volume | 7 |
| Q26852056 | Adenosine kinase: exploitation for therapeutic gain |
| Q89829276 | CD73 or CD39 Deletion Reveals Different Mechanisms of Formation for Spontaneous and Mechanically Stimulated Adenosine and Sex Specific Compensations in ATP Degradation |
| Q57287025 | Caffeine Modulates Spontaneous Adenosine and Oxygen Changes during Ischemia and Reperfusion |
| Q27303057 | Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury |
| Q55039936 | Early changes in transient adenosine during cerebral ischemia and reperfusion injury. |
| Q36567035 | Inhibition of pre-ischeamic conditioning in the mouse caudate brain slice by NMDA- or adenosine A1 receptor antagonists |
| Q47442352 | Nanoparticle-Based Therapeutics for Brain Injury |
| Q90285586 | Proof of concept and feasibility studies examining the influence of combination ribose, adenine and allopurinol treatment on stroke outcome in the rat |
| Q42378898 | Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation. |
| Q36243020 | Role of REM Sleep, Melanin Concentrating Hormone and Orexin/Hypocretin Systems in the Sleep Deprivation Pre-Ischemia |
| Q27311418 | Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. |
| Q37794392 | Targeting Astrocytes for Stroke Therapy |
| Q48098368 | The application of nanoparticles for neuroprotection in acute ischemic stroke |
Search more.